Press Release

Zurich (CH), Leonberg (DE) and Devens (MA, USA).

ChromaCon AG has entered into a licensing agreement with LEWA GmbH and LEWA Process Technologies. The agreement covers intellectual property relating to GMP scale up of cyclic and continuous processing of biopharmaceuticals. This agreement will enable the further development of each company’s current and future biopharmaceutical manufacturing technologies. As a result of the agreement, the biopharmaceutical industry can expect significant cost savings and quality benefits in downstream processing. (Press Release)